Safety-Related Labeling Changes

"Updated safety information and contraindications related to use iof Ixifi in patients with moderate or severe heart failure at doses >5 mg/kg Updated safety information in pediatric patients Updated safety information in Pregnant patients Updated undesirable effects ""Immunogenicity, Interstitial lung disease """

Trade Name

Ixifi

Updated Section

"4.3 Contraindications 4.4 Special Warnings and Special Precautions for Use 4.6. Fertility, pregnancy and lactation 4.8 Undesirable effects"

Month

Jul, 2024